Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Relapsed Acute Myeloid Leukemia.

A surge in flu cases across Scotland has placed health services in the country under "acute pressure", Public Health Scotland (PHS) has warned. Data from PHS showed 1,163 people were hospitalised ...

for the treatment of children and adults living with Friedreich ataxia (FA) to the U.S. Food and Drug Administration (FDA). "We are excited to have reached this important milestone in the ...